Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
SI-Bone Inc (SIBN)
NASDAQ:SIBN
Holding SIBN?
Track your performance easily
SIBN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.70 - $21.70
Previous Close$13.56
Volume147.81K
Average Volume (3M)372.61K
Market Cap
$568.68M
Enterprise Value$456.40M
Total Cash (Recent Filing)$150.82M
Total Debt (Recent Filing)$38.54M
Price to Earnings (P/E)―
Beta1.12
Next Earnings
Mar 03, 2025EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.91
Shares Outstanding41,938,179
10 Day Avg. Volume483,090
30 Day Avg. Volume372,614
Standard Deviation0.15
R-Squared0.18
Alpha-0.00605
Financial Highlights & Ratios
Price to Book (P/B)3.09
Price to Sales (P/S)3.29
Price to Cash Flow (P/CF)427.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.91
Enterprise Value/Gross Profit4.17
Enterprise Value/Ebitda-15.61
Forecast
1Y Price Target
$22.71Price Target Upside67.48% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
SI-Bone News
PremiumCompany Announcements
SI-BONE Reports Strong Q3 Growth and Optimistic Outlook
Bulls Say, Bears Say
Bulls Say
Financial PerformanceGross margin of 79.1% was above estimates, driven by product mix changes and supply chain optimization.
Operational ExpansionSIBN posted year-over-year and sequential growth in active surgeons, signaling expansion in its operational platform.
Product DevelopmentManagement announced that iFuse TORQ TNT, an anatomy-specific implant system, has received 510k breakthrough designation.
Bears Say
Financial PerformanceSIBN’s 3Q24 revenue missed consensus given a modest impact from Hurricane Helene and slower seasonality and management lowered the mid-point of its revenue guidance.
Guidance And ExpectationsSIBN decreased the top line of its guidance for FY24 due to impacts from hurricane/IV fluid shortage, leading to cautious expectations for Q4.
Regulatory InvestigationsSIBN disclosed that it received a civil investigative demand from the US Department of Justice relating to meals and consulting service payments to healthcare professionals.
---
Risk Analysis
Main Risk Category
ProductionRisks related to the company’s ability to manufacture goods and services
SIBN FAQ
What was SI-Bone Inc’s price range in the past 12 months?
SI-Bone Inc lowest stock price was $11.70 and its highest was $21.70 in the past 12 months.
What is SI-Bone Inc’s market cap?
Currently, no data Available
When is SI-Bone Inc’s upcoming earnings report date?
SI-Bone Inc’s upcoming earnings report date is Mar 03, 2025 which is in 72 days.
How were SI-Bone Inc’s earnings last quarter?
SI-Bone Inc released its earnings results on Nov 12, 2024. The company reported -$0.16 earnings per share for the quarter, beating the consensus estimate of -$0.239 by $0.079.
Is SI-Bone Inc overvalued?
According to Wall Street analysts SI-Bone Inc’s price is currently Undervalued.
Does SI-Bone Inc pay dividends?
SI-Bone Inc does not currently pay dividends.
What is SI-Bone Inc’s EPS estimate?
SI-Bone Inc’s EPS estimate is -$0.15.
How many shares outstanding does SI-Bone Inc have?
SI-Bone Inc has 41,938,180 shares outstanding.
What happened to SI-Bone Inc’s price movement after its last earnings report?
SI-Bone Inc reported an EPS of -$0.16 in its last earnings report, beating expectations of -$0.239. Following the earnings report the stock price went down -15.931%.
Which hedge fund is a major shareholder of SI-Bone Inc?
Among the largest hedge funds holding SI-Bone Inc’s share is Royce & Associates LLC. It holds SI-Bone Inc’s shares valued at 2M.
---
SI-Bone Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.71 (67.48% Upside)
$22.71 (67.48% Upside)
Blogger Sentiment
Bullish
SIBN Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 85.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $321.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-26.30%
12-Months-Change
Fundamentals
Return on Equity
-22.09%
Trailing 12-Months
Asset Growth
-1.68%
Trailing 12-Months
Company Description
SI-Bone Inc
SI-BONE, Inc. is a medical device company, which engages in the research and development of minimally invasive surgical implant system. Its product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.
---
SIBN Company Deck
---
SIBN Earnings Call
Q3 2024
0:00 / 0:00
---
SIBN Stock 12 Month Forecast
Average Price Target
$22.71
▲(67.48% Upside)
Technical Analysis
Inspire Medical Systems
―
Alphatec Holdings
―
Semler Scientific
―
Tandem Diabetes Care
―
Best Analysts Covering SIBN
1 Year
1 Year Success Rate
7/17 ratings generated profit
1 Year Average Return
+6.24%
reiterated a buy rating last month
Copying Drew Ranieri's trades and holding each position for 1 Year would result in 41.18% of your transactions generating a profit, with an average return of +6.24% per trade.
---